Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea

This publication has 67 references indexed in Scilit:

• Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis
  Expert Opinion on Pharmacotherapy, 2003
• Thymidine Rescue: An Antidote for Pemetrexed-Related Toxicity in the Setting of Acute Renal Failure
  Journal of Clinical Oncology, 2003
• Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869
  Cancer, 2002
• Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial
  European Journal Of Cancer, 2001
• Disposition and metabolism of the flavonoid chrysin in normal volunteers
  British Journal of Clinical Pharmacology, 2001
• Antiemetic Study Methodology: Recommendations for Future Studies
  Oncology, 1996
• Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats
  Japanese Journal of Cancer Research, 1995
• A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues
  European Journal of Cancer and Clinical Oncology, 1988
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983
• Emesis as a Critical Problem in Chemotherapy
  New England Journal of Medicine, 1981